Annual Total Assets
$170.95 M
-$177.58 M-50.95%
December 31, 2023
Summary
- As of February 8, 2025, INO annual total assets is $170.95 million, with the most recent change of -$177.58 million (-50.95%) on December 31, 2023.
- During the last 3 years, INO annual total assets has fallen by -$368.82 million (-68.33%).
- INO annual total assets is now -68.33% below its all-time high of $539.77 million, reached on December 31, 2020.
Performance
INO Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$107.06 M
-$26.74 M-19.98%
September 30, 2024
Summary
- As of February 8, 2025, INO quarterly total assets is $107.06 million, with the most recent change of -$26.74 million (-19.98%) on September 30, 2024.
- Over the past year, INO quarterly total assets has dropped by -$63.89 million (-37.37%).
- INO quarterly total assets is now -83.65% below its all-time high of $654.86 million, reached on March 31, 2021.
Performance
INO Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
INO Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -51.0% | -37.4% |
| 3 y3 years | -68.3% | -76.7% |
| 5 y5 years | +30.4% | -76.7% |
INO Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -65.5% | at low | -78.4% | at low |
| 5 y | 5-year | -68.3% | +18.8% | -83.7% | at low |
| alltime | all time | -68.3% | +3054.6% | -83.7% | +2830.7% |
Inovio Pharmaceuticals Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $107.06 M(-20.0%) |
| Jun 2024 | - | $133.80 M(+3.6%) |
| Mar 2024 | - | $129.11 M(-24.5%) |
| Dec 2023 | $170.95 M(-51.0%) | $170.95 M(-11.5%) |
| Sep 2023 | - | $193.10 M(-17.1%) |
| Jun 2023 | - | $233.04 M(-12.6%) |
| Mar 2023 | - | $266.58 M(-23.5%) |
| Dec 2022 | $348.53 M(-29.7%) | $348.53 M(-11.1%) |
| Sep 2022 | - | $391.97 M(-14.7%) |
| Jun 2022 | - | $459.40 M(+3.1%) |
| Mar 2022 | - | $445.51 M(-10.2%) |
| Dec 2021 | $495.94 M(-8.1%) | $495.94 M(-7.4%) |
| Sep 2021 | - | $535.76 M(-9.5%) |
| Jun 2021 | - | $591.84 M(-9.6%) |
| Mar 2021 | - | $654.86 M(+21.3%) |
| Dec 2020 | $539.77 M(+275.0%) | $539.77 M(+23.3%) |
| Sep 2020 | - | $437.81 M(-1.2%) |
| Jun 2020 | - | $443.19 M(+30.8%) |
| Mar 2020 | - | $338.92 M(+135.4%) |
| Dec 2019 | $143.95 M(+9.8%) | $143.95 M(-5.0%) |
| Sep 2019 | - | $151.53 M(-8.2%) |
| Jun 2019 | - | $165.07 M(-13.6%) |
| Mar 2019 | - | $191.17 M(+45.8%) |
| Dec 2018 | $131.11 M(-30.0%) | $131.11 M(-6.8%) |
| Sep 2018 | - | $140.70 M(-5.5%) |
| Jun 2018 | - | $148.92 M(-14.2%) |
| Mar 2018 | - | $173.66 M(-7.2%) |
| Dec 2017 | $187.24 M(+7.8%) | $187.24 M(-8.1%) |
| Sep 2017 | - | $203.68 M(+28.2%) |
| Jun 2017 | - | $158.85 M(+3.6%) |
| Mar 2017 | - | $153.31 M(-11.7%) |
| Dec 2016 | $173.71 M(-18.8%) | $173.71 M(-10.7%) |
| Sep 2016 | - | $194.55 M(-4.6%) |
| Jun 2016 | - | $203.99 M(-3.5%) |
| Mar 2016 | - | $211.29 M(-1.2%) |
| Dec 2015 | $213.84 M(+62.3%) | $213.84 M(-7.3%) |
| Sep 2015 | - | $230.77 M(+14.4%) |
| Jun 2015 | - | $201.70 M(+71.1%) |
| Mar 2015 | - | $117.86 M(-10.6%) |
| Dec 2014 | $131.79 M(+49.3%) | $131.79 M(-2.0%) |
| Sep 2014 | - | $134.53 M(-5.4%) |
| Jun 2014 | - | $142.15 M(-6.3%) |
| Mar 2014 | - | $151.66 M(+71.8%) |
| Dec 2013 | $88.29 M(+95.6%) | $88.29 M(+0.3%) |
| Sep 2013 | - | $88.02 M(+72.6%) |
| Jun 2013 | - | $50.99 M(-12.4%) |
| Mar 2013 | - | $58.20 M(+28.9%) |
| Dec 2012 | $45.14 M(-26.1%) | $45.14 M(+1.5%) |
| Sep 2012 | - | $44.48 M(-8.5%) |
| Jun 2012 | - | $48.60 M(-12.2%) |
| Mar 2012 | - | $55.35 M(-9.4%) |
| Dec 2011 | $61.11 M | $61.11 M(-3.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2011 | - | $63.27 M(-6.8%) |
| Jun 2011 | - | $67.86 M(-9.3%) |
| Mar 2011 | - | $74.85 M(+33.5%) |
| Dec 2010 | $56.07 M(-30.5%) | $56.07 M(-5.5%) |
| Sep 2010 | - | $59.32 M(-1.6%) |
| Jun 2010 | - | $60.28 M(-24.4%) |
| Mar 2010 | - | $79.72 M(-1.1%) |
| Dec 2009 | $80.63 M(+106.8%) | $80.63 M(-10.8%) |
| Sep 2009 | - | $90.44 M(+42.9%) |
| Jun 2009 | - | $63.27 M(+75.8%) |
| Mar 2009 | - | $35.98 M(-7.7%) |
| Dec 2008 | $38.99 M(-2.0%) | $38.99 M(+27.9%) |
| Sep 2008 | - | $30.48 M(-5.5%) |
| Jun 2008 | - | $32.26 M(-9.7%) |
| Mar 2008 | - | $35.72 M(-10.2%) |
| Dec 2007 | $39.77 M(+10.6%) | $39.77 M(-2.7%) |
| Sep 2007 | - | $40.87 M(-7.9%) |
| Jun 2007 | - | $44.35 M(+39.0%) |
| Mar 2007 | - | $31.92 M(-11.2%) |
| Dec 2006 | $35.95 M(+24.1%) | $35.95 M(+80.6%) |
| Sep 2006 | - | $19.90 M(-13.6%) |
| Jun 2006 | - | $23.03 M(-11.4%) |
| Mar 2006 | - | $25.98 M(-10.4%) |
| Dec 2005 | $28.98 M(+38.3%) | $28.98 M(+82.1%) |
| Sep 2005 | - | $15.92 M(-21.0%) |
| Jun 2005 | - | $20.15 M(-11.9%) |
| Mar 2005 | - | $22.88 M(+9.2%) |
| Dec 2004 | $20.95 M(+29.1%) | $20.95 M(-7.4%) |
| Sep 2004 | - | $22.63 M(-8.3%) |
| Jun 2004 | - | $24.68 M(+57.3%) |
| Mar 2004 | - | $15.68 M(-3.4%) |
| Dec 2003 | $16.23 M(+199.5%) | $16.23 M(+63.1%) |
| Sep 2003 | - | $9.95 M(+172.5%) |
| Jun 2003 | - | $3.65 M(-26.6%) |
| Mar 2003 | - | $4.98 M(-8.1%) |
| Dec 2002 | $5.42 M(-18.3%) | $5.42 M(-17.3%) |
| Sep 2002 | - | $6.55 M(-16.9%) |
| Jun 2002 | - | $7.88 M(+49.9%) |
| Mar 2002 | - | $5.26 M(-25.6%) |
| Dec 2001 | $6.63 M(-42.2%) | - |
| Sep 2001 | - | $7.06 M(-20.7%) |
| Jun 2001 | - | $8.91 M(-22.5%) |
| Mar 2001 | - | $11.49 M(+25.1%) |
| Mar 2001 | $11.49 M(-18.0%) | - |
| Dec 2000 | - | $9.18 M(-16.6%) |
| Sep 2000 | - | $11.01 M(-13.4%) |
| Jun 2000 | - | $12.71 M(-9.3%) |
| Mar 2000 | $14.01 M(+42.9%) | $14.01 M(-7.8%) |
| Dec 1999 | - | $15.20 M(-8.4%) |
| Sep 1999 | - | $16.60 M(-8.8%) |
| Jun 1999 | - | $18.20 M(+85.6%) |
| Mar 1999 | $9.81 M | $9.81 M(-18.9%) |
| Dec 1998 | - | $12.10 M |
FAQ
- What is Inovio Pharmaceuticals annual total assets?
- What is the all time high annual total assets for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals annual total assets year-on-year change?
- What is Inovio Pharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals quarterly total assets year-on-year change?
What is Inovio Pharmaceuticals annual total assets?
The current annual total assets of INO is $170.95 M
What is the all time high annual total assets for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high annual total assets is $539.77 M
What is Inovio Pharmaceuticals annual total assets year-on-year change?
Over the past year, INO annual total assets has changed by -$177.58 M (-50.95%)
What is Inovio Pharmaceuticals quarterly total assets?
The current quarterly total assets of INO is $107.06 M
What is the all time high quarterly total assets for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high quarterly total assets is $654.86 M
What is Inovio Pharmaceuticals quarterly total assets year-on-year change?
Over the past year, INO quarterly total assets has changed by -$63.89 M (-37.37%)